Status:
UNKNOWN
Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsors:
Perspectum
Conditions:
PSC
MRI
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary sclerosing cholangitis (PSC) is a chronic progressive biliary disease. Due to the heterogeneous disease course and the relatively low clinical event rate of 5% per year it is difficult to pred...
Detailed Description
After informed consent, patients will undergo standard care with blood tests and MRI/MRCP. While performing the MRI, additional sequences called LMS are performed. Thereafter, an ERCP will be performe...
Eligibility Criteria
Inclusion
- Established diagnosis according to the IPSCSG Definitions (22)
- Age ≥ 18
- Able to give informed consent
- Clinically suspicious for a dominant stricture
Exclusion
- insufficient image quality
- known allergy for MRI contrast agents
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05359497
Start Date
May 1 2022
End Date
December 1 2023
Last Update
May 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.